Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Verisk Analytics Q3 2026: Revenue Rises to $809M

Verisk Analytics, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 5, 2026, reporting third-quarter revenues of $809.0 million and net income of $219.2 million.

Manish Choudhary | 05 November 2026

Vistance Networks Q3 2026: Net Income $1.03B on Divestitures

Vistance Networks, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, reporting net income of $1,030.6 million for the third quarter and $6,833.7 million for the nine months ended …

Aakashdeep | 05 November 2026

REGENXBIO Q3 2026 10-Q: 66.1M Shares Outstanding

REGENXBIO Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission for the period ended September 30, 2026, disclosing share count, filing status, and key operational and regulatory risk factors as of November 5, 2026.

Aditi Sarkar | 05 November 2026

C4 Therapeutics Files Q3 2026 Report, 131M Shares Out

C4 Therapeutics, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, disclosing operational details, risk factors, and share count information for the third quarter.

Nitish Kishor | 05 November 2026

Latigo Biotherapeutics Files Q3 2026 Report with 66.3M Shares

Latigo Biotherapeutics, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 5, 2026, covering the fiscal quarter ended September 30, 2026.

Aakashdeep | 05 November 2026

Vistance Networks Adds $100M Buyback, Reports Q3 2026 Results

Vistance Networks, Inc. filed an 8-K with the U.S. Securities and Exchange Commission on November 5, 2026, disclosing a new $100 million share repurchase authorization and the release of its third-quarter 2026 financial results.

Aditi Sarkar | 05 November 2026

Dyne Therapeutics Q3 2026 10-Q: 187M Shares Outstanding

Dyne Therapeutics, Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the fiscal quarter ended September 30, 2026.

Manish Choudhary | 05 November 2026

ConocoPhillips Q3 2026 Earnings Results Filed November 5

ConocoPhillips filed a Form 8-K on November 5, 2026, disclosing its financial and operating results for the quarter ended September 30, 2026, through a press release and supplemental financial information furnished as exhibits.

Nitish Kishor | 05 November 2026

Cogent Q3 2026: Wavelength Revenue Jumps 57% Year-Over-Year

Cogent Communications Holdings, Inc. filed its third-quarter 2026 earnings disclosure on November 5, 2026, reporting service revenue of $231.2 million for the three months ended September 30, 2026, alongside debt repurchases and two non-binding letters of intent to sell four data centers.

Manish Choudhary | 05 November 2026

Ceragon Q3 2026 Revenue Rises 11.7% to $95.5M

Ceragon Networks Ltd. (NASDAQ:CRNT) reported its financial results for the third quarter ended September 30, 2026, via a press release filed on November 5, 2026, disclosing revenue growth of 11.7% year-over-year and positive operating cash flow of $14.1 million.

Aditi Sarkar | 05 November 2026
Support

Hi! How can we help you today?

Loading…